In summary, we believe that by targeting and downregulating GRAMD1B, miR-4646-5p exerts a tumor-suppressive effect, as it thereby might impair the transport and thus the use of exogenous cholesterol, which has been reported to constitute a vital pro-oncogenic source for breast cancer cells. Here, GRAMD1B is linked to breast carcinoma.